Long‐term response with durvalumab after chemoradiotherapy for pulmonary pleomorphic carcinoma: A case report

Pulmonary pleomorphic carcinoma (PPC) is a non‐small‐cell lung cancer, resistant to chemotherapy and no standard therapy has as yet been established. We herein report the case of a 59‐year‐old man with PPC who showed a long‐term response with durvalumab after chemoradiotherapy. He was referred to ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Yorozuya, Takafumi, Taya, Tetsuya, Yasuda, Kento, Nagano, Yutaro, Shioya, Makoto, Chiba, Hirofumi, Takahashi, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113037/
https://www.ncbi.nlm.nih.gov/pubmed/32045109
http://dx.doi.org/10.1111/1759-7714.13331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113037/
https://www.ncbi.nlm.nih.gov/pubmed/32045109
http://dx.doi.org/10.1111/1759-7714.13331

Ejemplares similares